Home > Insider Trading > Filing (0000912282-23-000549)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1776738	Cannabist Co Holdings Inc.	CBSTF	Agricultural Production-Crops (100)	981488978

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1907623	Nicholas Vita	C/O The Cannabist Company Holdings Inc. 680 Fifth Avenue, 24Th Floor New York NY 10019	Chief Executive Officer	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares	Disposition	2023-12-04	150,000	$0.35	20,777,075	No	4	S	Indirect	Held by Vita Holdings LLC
Common Shares	Disposition	2023-12-05	200,000	$0.35	20,577,075	No	4	S	Indirect	Held by Vita Holdings LLC

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	Held by Vita Holdings LLC
No	4	S	Indirect	Held by Vita Holdings LLC

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Shares	618,950	Direct

Footnotes

The sales price reported above was converted from the Canadian weighted average price of $0.478333 using an exchange rate of C$1.3541 = US$1.00. These shares were sold in multiple transactions at prices ranging from C$0.47 to $0.485, inclusive. The Reporting Person undertakes to provide to The Cannabist Company Holdings Inc., any security holder of The Cannabist Company Holdings Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The sale price reported above was converted from the Canadian weighted average price of C$0.48125 using an exchange rate of C$1.3579 = US$1.00. These shares were sold in multiple transactions at price ranging from C$0.48 to $0.485, inclusive. The Reporting Person undertakes to provide to The Cannabist Company Holdings Inc., any security holder of The Cannabist Company Holdings Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
Shares sold by third-party financial institution in partial satisfaction of debt obligation. Funding was primarily used for pediatric medical research for orphan and ultra rare illnesses, tax payments, education and philanthropic purposes.